Global CAR T-Cell Therapy Market Share

Market Share of Global CAR T-Cell Therapy Industry

The CAR T-Cell therapy market is moderately competitive with several global and international players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are Novartis AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc. (Kite Pharma), Johnson & Johnson, and Sorrento Therapeutics, Inc., among other players.

Car T-Cell Therapy Market Leaders

1. Novartis AG

2. Bristol-Myers Squibb Company

3. Johnson & Johnson

4. Sorrento Therapeutics, Inc.

5. Gilead Sciences, Inc. (Kite Pharma)

*Disclaimer: Major Players sorted in no particular order